Target intelligence / Profile preview

Voltage-gated potassium channel subfamily K member 2 (Kv7.2)

Target
Kv7.2
Molecular classification
Voltage-gated potassium channel, KCNQ family, Kv7 subfamily
01

Overview

Kv7.2 is a voltage-gated potassium channel encoded by the KCNQ2 gene and is a key member of the Kv7 family. It functions as a tetramer of alpha subunits, which can be homomeric Kv7.2 or heteromeric, most notably with Kv7.3 subunits, to form the neuronal M-current. Each subunit has six transmembrane segments (S1-S6), cytoplasmic N- and C-termini. The S1-S4 segments form the voltage-sensing domain, while S5-S6 and the linker form the pore domain. A distinctive long C-terminus contains domains for tetramerization and binding sites for regulatory molecules like PIP2, calmodulin, syntaxin, etc. Kv7.2 channels generate voltage-activated, slowly activating, and non-inactivating potassium currents that open at subthreshold membrane potentials (around -60 mV). This current is essential for controlling neuronal excitability by setting the resting potential, determining spike threshold and firing frequency, preventing hyperexcitability, and mediating after-hyperpolarization. Channel activity is regulated by voltage, calcium-bound and unbound calmodulin, PIP2, and various signaling cascades. Mutations in the KCNQ2 gene leading to Kv7.2 dysfunction are associated with neuronal hyperexcitability and several neurological disorders, particularly epilepsy, making Kv7.2 an important therapeutic target. Pharmacologically, Kv7.2 channels can be modulated by drugs like the activators Retigabine and flupirtine, which shift the voltage-dependence of activation and are used to treat conditions involving neuronal hyperexcitability.

Other names
KCNQ2
02

Mechanism of action

Modulating neuronal excitability by increasing or decreasing the activity of Kv7.2 channels, often by shifting the voltage-dependence of channel activation.

03

Biological functions

Regulation of neuronal excitabilityComponent of M-currentMaintenance of resting membrane potentialSetting spiking thresholdDetermining firing frequencyPrevention of neuronal hyperexcitabilityInduction of after-hyperpolarization
04

Disease associations

EpilepsyNeurological disorders
05

Interacting drugs

Retigabine

1 more in the full profile.

Beyond the preview

Go deeper on Voltage-gated potassium channel subfamily K member 2 (Kv7.2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Voltage-gated potassium channel subfamily K member 2 (Kv7.2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call